These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3028828)

  • 1. [3H]CPP, a new competitive ligand for NMDA receptors.
    Olverman HJ; Monaghan DT; Cotman CW; Watkins JC
    Eur J Pharmacol; 1986 Nov; 131(1):161-2. PubMed ID: 3028828
    [No Abstract]   [Full Text] [Related]  

  • 2. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
    Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
    J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid to rat brain membranes: a selective, high-affinity ligand for N-methyl-D-aspartate receptors.
    Murphy DE; Schneider J; Boehm C; Lehmann J; Williams M
    J Pharmacol Exp Ther; 1987 Mar; 240(3):778-84. PubMed ID: 3031274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a functional coupling of the NMDA and glycine recognition sites in synaptic plasma membranes.
    Compton RP; Hood WF; Monahan JB
    Eur J Pharmacol; 1990 Jan; 188(1):63-70. PubMed ID: 2155123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioligand labeling of N-methyl-D-aspartic acid (NMDA) receptors by [3H](+-)-3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid in brain synaptic membranes treated with Triton X-100.
    Yoneda Y; Ogita K; Kouda T; Ogawa Y
    Biochem Pharmacol; 1990 Jan; 39(1):225-8. PubMed ID: 2153381
    [No Abstract]   [Full Text] [Related]  

  • 6. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
    Foster AC; Wong EH
    Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of organophosphate interactions at N-methyl-D-aspartate receptors in brain synaptic membranes.
    Johnson PS; Michaelis EK
    Mol Pharmacol; 1992 Apr; 41(4):750-6. PubMed ID: 1533269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guanine nucleotide modulation of [3H]TCP binding to the NMDA receptor complex.
    Hood WF; Thomas JW; Compton RP; Monahan JB
    Eur J Pharmacol; 1990 Jan; 188(1):43-9. PubMed ID: 2155121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamine mimics glycine to enhance [3H]TCP binding at the NMDA receptor complex.
    Stumpo RJ; Pullan LM; Salama AI
    Eur J Pharmacol; 1989 Oct; 170(1-2):121-2. PubMed ID: 2558893
    [No Abstract]   [Full Text] [Related]  

  • 10. [3H]glycine binding is modulated by Mg2+ and other ligands of the NMDA receptor-cation channel complex.
    Marvizón JC; Skolnick P
    Eur J Pharmacol; 1988 Jun; 151(1):157-8. PubMed ID: 2458270
    [No Abstract]   [Full Text] [Related]  

  • 11. Action of 3-((+/-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP): a new and highly potent antagonist of N-methyl-D-aspartate receptors in the hippocampus.
    Harris EW; Ganong AH; Monaghan DT; Watkins JC; Cotman CW
    Brain Res; 1986 Sep; 382(1):174-7. PubMed ID: 2876750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat brain N-methyl-D-aspartate receptors require multiple molecules of agonist for activation.
    Javitt DC; Frusciante MJ; Zukin SR
    Mol Pharmacol; 1990 May; 37(5):603-7. PubMed ID: 2160056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of thyroid hormones with L-(3H) glutamate binding sites, with special reference to N-methyl-D-aspartate receptors.
    Oguro K; Ito M; Tsuda H; Mutoh K; Shiraishi H; Shirasaka Y; Mikawa H
    Res Commun Chem Pathol Pharmacol; 1989 Aug; 65(2):181-96. PubMed ID: 2555853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative autoradiographic localization of NMDA receptors in rat brain using [3H]CPP: comparison with [3H]TCP binding sites.
    Jarvis MF; Murphy DE; Williams M
    Eur J Pharmacol; 1987 Sep; 141(1):149-52. PubMed ID: 2822443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of NMDA receptors labelled with [3H]3-((+-)-2-carboxypiperazin-4-yl) propyl-1-phosphonic acid ([3H]CPP): receptor status in Alzheimer's disease brains.
    Porter RH; Cowburn RF; Alasuzoff I; Briggs RS; Roberts PJ
    Eur J Pharmacol; 1992 Mar; 225(3):195-201. PubMed ID: 1387617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abolition of the NMDA-mediated responses by a specific glycine antagonist, 6,7-dichloroquinoxaline-2,3-dione (DCQX).
    Yoneda Y; Ogita K
    Biochem Biophys Res Commun; 1989 Oct; 164(2):841-9. PubMed ID: 2554902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for direct interactions between the NMDA and glycine recognition sites in brain.
    Kaplita PV; Ferkany JW
    Eur J Pharmacol; 1990 Mar; 188(2-3):175-9. PubMed ID: 2156714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective enhancement by (R)-HA-966 of the binding of [3H]CPP to the NMDA receptor complex.
    Pullan LM; Powel RJ; Stumpo RJ; Britt M; Klika AB; Meiners BA; Salama AI
    Eur J Pharmacol; 1990 Sep; 189(2-3):237-40. PubMed ID: 2147657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nitric oxide on L-[3H]glutamate binding to rat brain synaptic membranes.
    Fujimori H; Pan-Hou H
    Brain Res; 1991 Jul; 554(1-2):355-7. PubMed ID: 1657294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-methyl-D-aspartate receptor plasticity in kindling: quantitative and qualitative alterations in the N-methyl-D-aspartate receptor-channel complex.
    Yeh GC; Bonhaus DW; Nadler JV; McNamara JO
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8157-60. PubMed ID: 2479019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.